KNSA
insider transactionsKiniksa Pharmaceuticals International, plc — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·C
Sanj K Patel KEY
CHAIRMAN & CEO
$0
900.0K sh
Own New
-
Exercise·C
Sanj K Patel KEY
CHAIRMAN & CEO
—
900.0K sh
Own +1738%
-
Exercise·M
Director
$0
2.8K sh
Own New
-
Grant·A
Director
$0
2.0K sh
Own New
-
Grant·A
Director
$0
12.2K sh
Own New
-
Exercise·M
Director
—
2.8K sh
Own +22%
-
Exercise·M
Director
$0
2.8K sh
Own New
-
Grant·A
Director
$0
2.0K sh
Own New
-
Grant·A
Director
$0
12.2K sh
Own New
-
Exercise·M
Director
—
2.8K sh
Own +15%
-
Exercise·M
Director
$0
2.8K sh
Own New
-
Grant·A
Director
$0
2.0K sh
Own New
-
Grant·A
Director
$0
12.2K sh
Own New
-
Exercise·M
Director
—
2.8K sh
Own +22%
-
Exercise·M
Director
$0
2.8K sh
Own New
-
Grant·A
Director
$0
2.0K sh
Own New
-
Grant·A
Director
$0
12.2K sh
Own +45030%
-
Exercise·M
Director
—
2.8K sh
Own +22%
-
Exercise·M
Director
$0
2.8K sh
Own New
-
Grant·A
Director
$0
2.0K sh
Own New
-
Grant·A
Director
$0
12.2K sh
Own New
-
Exercise·M
Director
—
2.8K sh
Own +22%
-
Exercise·M
Director
$0
2.8K sh
Own New
-
Grant·A
Director
$0
2.0K sh
Own New
-
Grant·A
Director
$0
12.2K sh
Own New
-
Exercise·M
Director
—
2.8K sh
Own +22%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | Sanj K Patel KEY | Exercise C | 900.0K | $0 |
| Jun 1, 2026 | Sanj K Patel KEY | Exercise C | 900.0K | — |
| May 29, 2026 | Tracey L Mccain | Exercise M | 2.8K | $0 |
| May 29, 2026 | Tracey L Mccain | Grant A | 2.0K | $0 |
| May 29, 2026 | Tracey L Mccain | Grant A | 12.2K | $0 |
| May 29, 2026 | Tracey L Mccain | Exercise M | 2.8K | — |
| May 29, 2026 | Richard S Levy | Exercise M | 2.8K | $0 |
| May 29, 2026 | Richard S Levy | Grant A | 2.0K | $0 |
| May 29, 2026 | Richard S Levy | Grant A | 12.2K | $0 |
| May 29, 2026 | Richard S Levy | Exercise M | 2.8K | — |
| May 29, 2026 | Thomas Malley | Exercise M | 2.8K | $0 |
| May 29, 2026 | Thomas Malley | Grant A | 2.0K | $0 |
| May 29, 2026 | Thomas Malley | Grant A | 12.2K | $0 |
| May 29, 2026 | Thomas Malley | Exercise M | 2.8K | — |
| May 29, 2026 | Barry D Quart | Exercise M | 2.8K | $0 |
| May 29, 2026 | Barry D Quart | Grant A | 2.0K | $0 |
| May 29, 2026 | Barry D Quart | Grant A | 12.2K | $0 |
| May 29, 2026 | Barry D Quart | Exercise M | 2.8K | — |
| May 29, 2026 | Kimberly J Popovits | Exercise M | 2.8K | $0 |
| May 29, 2026 | Kimberly J Popovits | Grant A | 2.0K | $0 |
| May 29, 2026 | Kimberly J Popovits | Grant A | 12.2K | $0 |
| May 29, 2026 | Kimberly J Popovits | Exercise M | 2.8K | — |
| May 29, 2026 | Bradley G Cole | Exercise M | 2.8K | $0 |
| May 29, 2026 | Bradley G Cole | Grant A | 2.0K | $0 |
| May 29, 2026 | Bradley G Cole | Grant A | 12.2K | $0 |
| May 29, 2026 | Bradley G Cole | Exercise M | 2.8K | — |
About KNSA insider trading
This page tracks insider transactions for Kiniksa Pharmaceuticals International, plc (KNSA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.